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Purpose: Tubulointerstitial hypoxia in the kidney is considered a hallmark of injury 
and a mediator of the progression of tubulointerstitial fibrosis. Hypoxia-inducible 
factor-1alpha (HIF-1alpha), a master transcription factor in cellular adaptation to hy-
poxia, regulates a wide variety of genes, some of which are closely associated with 
tissue fibrosis. The present study set out to characterize urinary HIF-1alpha expres-
sions in patients with lupus nephritis (LN) and to explore whether urinary HIF-1al-
pha expressions are associated with histologic chronicity changes and renal function. 
Materials and Methods: Urinary HIF-1alpha levels were measured by enzyme-
linked immunosorbent assays in 42 patients with LN and in 30 healthy controls. Ac-
tivity and chronicity indexes as well as tubular HIF-1alpha expressions were ana-
lyzed for each specimen. Results: Urinary HIF-1alpha levels were higher in LN 
patients than in healthy controls (3.977±1.696 vs. 2.153±0.554 ng/mL, p<0.001) and 
were associated with histologic chronicity indexes (r=0.463, p<0.01) and eGFR (r=-
0.324, p<0.05). However, urinary HIF-1alpha levels showed no correlation with his-
tologic activity indexes, anti-dsDNA, ANA, complement 3 and 4 levels, proteinuria, 
systemic lupus erythematosis disease activity index, and WHO pathological classifi-
cation (p>0.05). Conclusion: Urinary HIF-1alpha levels were elevated in LN pa-
tients and were associated with histologic chronicity changes and renal function, in-
dicating that HIF-1alpha might contribute to histologic chronicity in LN.
Key Words:    Hypoxia-inducible factor-1alpha, lupus nephritis, histologic chronic-
ity change, renal function
INTRODUCTION
Lupus nephritis (LN) is one of the main causes of morbidity and mortality in sys-
temic lupus erythematosus (SLE).1 Although the glomerular abnormalities of LN 
have attracted much attention, the mechanisms that lead to tubulointerstitial fibro-
sis and damage in LN remain obscure. Tubulointerstitial injury is characterized by 
tubular atrophy and interstitial fibrosis.2 Pathological analysis shows that the extent Chunyang Ma, et al.
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record system. All 42 patients fulfilled at least four of the 
1997 American College of Rheumatology revised criteria 
for SLE and had persistent proteinuria greater than 0.5 g/
day or cellular casts, as described in the criteria for renal in-
volvement.20 This study was approved by the Institutional 
Review Board of Hainan Provincial People’s Hospital and 
informed consent from all patients was obtained.
Histological classification of LN and morphologic 
evaluation
Kidney specimens from 42 patients with LN were stained 
with hematoxylin-eosin and then classified according to the 
International Society of Nephrology/Renal Pathology Society 
2003 classification.21 Activity indices (AI) and chronicity indi-
ces (CI) were calculated in proliferative forms.22 Quantita-
tion of interstitial inflammation and chronic tubulo-intersti-
tial damage (TID) is based on the percentage of cortex 
involved by interstitial fibrosis and tubular atrophy. A semi-
quantitative grading of TID and interstitial inflammation 
was described as follows: 0=none; 1=involvement of 
<25%; 2=involvement of 26-50%; 3=involvement of 51-
75%; 4=involvement of  >76%.
Urinary HIF-1alpha assays
Urinary HIF-1alpha levels were measured in 42 patients 
with LN and 30 healthy controls, using an enzyme-linked 
immunosorbent assay kit (Groundwork Biotechnology Di-
agnostics Inc., San Diego, CA, USA, Catalogue number: 
H108-9). All experiments were performed in duplicate.
Statistical analysis
Statistical analysis was performed using SPSS software 
version 11.0. Results are reported as means±SD Student’s t-
test was used to compare urinary HIF-1alpha levels be-
tween the LN group and the control group. Correlations be-
tween two data sets were assessed using Spearman’s corre-
lation test. p-values of <0.05 were considered significant.
 
RESULTS
 
Patients’ demographic and clinical information
Table 1 summarizes the demographic and clinical informa-
tion of the 42 patients with LN. Fifteen (35.71%) patients 
demonstrated nephrotic range proteinuria. The most frequent 
histological class was WHO class IV (20/42, 47.62%). There 
were 8 cases with mixed classes: 5 with III plus V and 3 
of tubulointerstitial damage is better correlated with im-
paired renal function than the degree of glomerular injury 
in patients with chronic kidney disease (CKD) and it may 
be less amenable to treatment compared with glomerular 
lesions.3
Accumulating evidence emphasizes chronic hypoxia in 
the tubulointerstitium as a final common pathway to end-
stage renal disease (ESRD), and the final common pathway 
of chronic hypoxia operates principally in the tubulointersti-
tium.4,5 Renal hypoxia in early and late stage of CKD is sec-
ondary to imbalances in vasoactive factors, obliteration and 
loss of the interstitial capillary, reduced efficiency of oxygen 
diffusion, increased oxygen demand from hyperfiltration 
and tubular hypertrophy.5-9 Recent evidence shows that hy-
poxia may accelerate CKD progression by affecting renal 
cell survival, inflammatory cell infiltration, ECM deposition, 
and epithelial to mesenchymal transition (EMT).6,7,10,11 
The family of hypoxia-inducible factors (HIFs) are cen-
tral regulators of hypoxic responses.12 HIFs regulate several 
target genes that have important functions in renal physio-
logic and pathophysiologic processes, including energy me-
tabolism, vasomotor regulation, angiogenic growth, matrix 
metabolism, and apoptosis/cell survival.13-17 HIF-1 is a het-
erodimer composed of a constitutively expressed HIF-1β 
subunit and an O2-regulated HIF-1alpha subunit. HIF-1al-
pha plays a central role in the hypoxic response of tubular 
epithelial cells.10 Indeed, hypoxia-inducible gene expres-
sion in primary renal proximal tubular epithelial cells is al-
most completely blocked by inactivation of HIF-1alpha, 
suggesting that their response to hypoxia is largely depen-
dent on HIF-1alpha.18 In addition, genetic ablation of HIF-
1alpha inhibited the development of tubulointerstitial fibro-
sis in vivo.19 In summary, HIF-1alpha appears to be a critical 
contributor to the progression of tubulointerstitial fibrosis 
due to hypoxia.
In this study, we investigated urinary HIF-1alpha levels 
in patients with LN and analyzed the associations between 
urinary HIF-1alpha levels and the clinical features in LN 
patients.
MATERIALS AND METHODS
　　　
Subjects 
Forty-two patients with LN who underwent renal biopsy at 
Hainan Provincial People’s Hospital from 2003 January to 
2010 December were identified via an electronic medical Urinary HIF-1alpha Levels in Patients with LN
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p<0.01) (Fig. 1B) and eGFR (r=-0.324, p<0.05) (Fig. 1C), 
but not with anti-dsDNA, ANA, C3, C4, daily proteinuria 
amounts or histologic AI.
DISCUSSION
LN is a severe organ manifestation of SLE and a major 
cause of morbidity. Whereas the immunopathogenesis of 
with IV plus V (Table 1).
Urinary HIF-1alpha levels in patients with LN and in 
healthy controls and correlation between urinary HIF-
1alpha levels and the clinical parameters of LN
Urinary HIF-1alpha levels were significantly higher in pa-
tients with LN than in healthy controls (3.977±1.696 vs. 
2.153±0.554 ng/mL, p<0.001) (Fig. 1A). Urinary HIF-1al-
pha levels were associated with histologic CI (r=0.463, 
Table 1. Patients’ Demographic and Clinical Information
LN patients Normal control
Number  42  30
Age (mean±SD, yrs)   24.07±11.14      31.2±8.55
Gender, female      38 (90.48%) 18 (60%)
SBP (mm Hg) 122.71±28.06 109.33±9.8
DBP (mm Hg)   80.81±18.12     66.17±5.52
Complement 3 (g/L)   0.51±0.28
Complement 4 (g/L)   0.12±0.07
Positive rate of ANA, n (%)      32 (76.19%)
Positive rate of anti-dsDNA, n (%) 21 (50%)
Albumin (g/L) 25.98±6.44
Proteinuria (g/d)   3.08±2.07
eGFR (mL/min/1.73 m
2)   82.80±35.75
SLEDAI 13.17±5.56
WHO classification
    II      2 (4.76%)
    III      5 (11.9%)
    IV      20 (47.62%)
    V        7 (16.67%)
    III plus V      5 (11.9%)
    IV plus V       3 (7.14%)
LN, lupus nephritis; SD, standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure; ANA, antinuclear antibody; eGFR, estimated glomeru-
lar filtration rate; SLEDAI, systemic lupus erythematosis disease activity index; WHO, World Health Organization.
Values are expressed as mean±SD or number of patients (percent).
Fig. 1. Urinary HIF-1alpha levels in patients with lupus nephritis and in healthy controls. Urinary HIF-1alpha levels were significantly higher in patients with 
lupus nephritis than in healthy controls (3.977±1.696 vs. 2.153±0.554 ng/mL, p<0.001). The bars indicate group mean values (A). Urinary HIF-1alpha levels were 
associated with histologic chronicity indices (r=0.463, p<0.01) (B) and eGFR (r=-0.324, p<0.05) (C). HIF, hypoxia-inducible transchiption factor.
2.0
0 0
1
25
2
3
50
4
75
5 100
6 125
4.0
6.0
8.0
U
r
i
n
a
r
y
 
H
I
F
-
1
a
l
p
h
a
 
l
e
v
e
l
s
 
(
n
g
/
m
L
)
H
i
s
t
o
l
o
g
i
c
 
c
h
r
o
n
i
c
i
t
y
 
i
n
d
e
x
e
s
e
G
F
R
 
(
m
L
/
m
i
n
/
1
.
7
3
 
m
2
)
Normal control 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 Lupus nephritis
Groups Urinary HIF-1alpha levels (ng/mL) Urinary HIF-1alpha levels (ng/mL)
p<0.001 r=0.463, p<0.01 r=-0.324, p<0.05
A B CChunyang Ma, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 590
found that urinary HIF-1alpha levels in LN patients were 
significantly higher than that of healthy controls, demon-
strating that HIF-1alpha is increasingly expressed in the tu-
bulointerstitial compartment vs. healthy subjects. 
Our study also found the good correlations between uri-
nary HIF-1alpha levels and the histological chronicity in-
dex eGFR, suggesting that expressed HIF-1alpha might 
participate in the chronicity and renal function of LN. Al-
though the chronicity index is known to represent fibrosis, 
the individual components of the chronicity index indicate 
the degree of fibrous tissue accumulation. Considering that 
HIF-1alpha is expressed in renal tubular epithelial cells, our 
finding that urinary HIF-1alpha levels might be more rea-
sonable to correlated with chronicity index than activity in-
dex. Thus, it would be interesting to investigate whether 
urinary HIF-1alpha levels can help predict renal outcome. 
In summary, urinary HIF-1alpha levels were elevated in 
LN patients and associated with histologic chronicity chang-
es and renal function, indicating that HIF-1alpha might con-
tribute to histologic chronicity and renal function in LN.
The limitations of our present study include the small 
number of patients enrolled and lack of control for renal 
disease groups, as cases of different types of glomerulone-
phritis (i.e. primary and secondary glomerulonephritis), as 
well as other tubulointerstitial diseases (i.e. allograft ne-
phropathy, drug-induced tubulointerstitial nephritis) or glo-
merular diseases without interstitial damage are present in 
all chronic renal damage cases. In addition, it remains to be 
proven that there is a positive correlation between urinary 
and renal HIF-1alpha levels and whether urinary HIF-1al-
pha levels accurately represent renal HIF-1alpha levels. 
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